Observation on the Curative Effect of Madopar Combined with Pramipexole in the Treatment of Parkinson’s Diseases

  • Yongting Yu
  • Min Yang
  • Ruihui Chen
  • Hongbing Chen
Keywords: madopar, pramipexole, Parkinson's disease, motor symptoms

Abstract

Parkinson’s disease is a common neurological degenerative disease in the elderly. The clinical manifestations are static tremor, increased muscle tone, slow movement, abnormal posture gait, and severe symptoms of loss of self-care. Parkinson’s disease has become a burden to not only patient, but also to his family and to the society. Normal human brain neurotransmitter dopamine and acetylcholine are in a balanced state, the two antagonism can maintain normal body function. The pathological changes of patients with Parkinson’s disease is degeneration and apoptosis of dopaminergic neurons in striatum, resulting in a significant reduction in dopamine levels, and thus lead to an imbalance in the effects of dopamine and acetylcholine, and a decrease in dopamine resistance to acetylcholine Parkinson’s disease symptoms. As such, this article will focus on the analysis of the Madopar and pramipexole in the treatment of Parkinson’s disease symptoms.

References

1. Wang X, Liu G, Xiao Q, Chen S. Dopamine receptor agonist pramipexole treatment of Parkinson’s disease non-motor symptoms of observation [J]. Journal of Clinical Neurology, 2010,04:299-301.
2. Hua Z. Pramipexole treatment of Parkinson’s disease non-exercise symptoms of observation [J] Practical Elderly Medicine, 2010,06:498-500.
3. Zheng J, Xu J, Liang Q, Ruan Z, Pan J. Dopamine receptor agonist pramipexole treatment of Parkinson’s disease non-motor symptoms of observation [J]. South China National Defense Medical Journal, 2014,06:586-587.
4. Chen S. Acupuncture combined with the United States and Duoba treatment of Parkinson’s disease clinical research [D]. Chinese Academy of Traditional Chinese Medicine, 2013.
5. Zhou T. Pluticaine hydrochloride treatment of Parkinson’s disease dose-effect relationship analysis [D]. Dalian Medical University, 2013.
6. Zhang K, Yuan Y, Song C, Zhang L. Pramipexole hydrochloride to improve the curative effect of non-motor symptoms of Parkinson’s disease [J]. Chinese Journal of Practical Neurology, 2012,14:11-14.
7. Liu Z, Pu Z, Liu Y, Yin P, Lu C, Zang Z. Medaoba combined with pramipine hydrochloride in the treatment of Parkinson’s disease on the role of motor function [J]. Chinese Journal of Practical Neurology, 2015, 15:94-95.
Published
2017-07-20
Section
Original Research Article